Watch Demo

Global Biochips Industry

Global Biochips Industry

  • Publish Date:January 2023

  • Number of Pages:369

  • Report ID:5478467

  • Format:PDF

  • Publisher:Global Industry Analysts

$ 5600

Summary

The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet. Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China’s already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Global Biochips Market to Reach $40.8 Billion by 2030

In the changed post COVID-19 business landscape, the global market for Biochips estimated at US$15.9 Billion in the year 2022, is projected to reach a revised size of US$40.8 Billion by 2030, growing at a CAGR of 12.5% over the analysis period 2022-2030. DNA Chip, one of the segments analyzed in the report, is projected to record a 11.4% CAGR and reach US$13.5 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Lab-On-a-chip segment is readjusted to a revised 13.1% CAGR for the next 8-year period.

The U.S. Market is Estimated at $6.3 Billion, While China is Forecast to Grow at 14.8% CAGR

The Biochips market in the U.S. is estimated at US$6.3 Billion in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$4.2 Billion by the year 2030 trailing a CAGR of 14.8% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 10.7% and 11.2% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 12.5% CAGR.

Select Competitors (Total 69 Featured)
- Agilent Technologies, Inc.
- Bio-Rad Laboratories, Inc.
- CapitalBio Technology Inc.
- Cepheid Inc.
- Fluidigm Corporation
- Hoffman-La-Roche Ltd.
- Illumina, Inc.
- OcimumBiosolutions Ltd.
- PerkinElmer, Inc.
- Takara Bio Inc.
- Takara Bio USA, Inc.
- Thermo Fisher Scientific Inc.

Table of contents

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession
2020 Marked as a Year of Disruption & Transformation
World Economic Growth Projections (Real GDP, Annual % Change)
for 2019 to 2022
Biotechnology Sector Performance amid the Pandemic
Global Biotechnology Market Reset & Trajectory - Growth Outlook
(In %) For Years 2019 Through 2025
Biochip Firms Get Ready to Address COVID-19 Challenge
Biochips - Global Key Competitors Percentage Market Share in
2022 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for
Players Worldwide in 2022 (E)
Biochips: A Primer
Manufacturing Systems Used in Biochip Manufacture
Historical Perspective
Classification of Biochips
Application Markets
Market Outlook
Protein Biochips Set for Expansion
Recent Technological Advancements Drive Wider Adoption of Biochips
Competition
Biotech Startups Pose Competition
Recent Market Activity
World Brands

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS
Biochips Seek Increasing Role in POC Testing
Biochips to Help Next-Generation Sequencing Scale New Heights &
Unravel Intimidating Biological Problems
Research Forays into Organ-On-A-Chip (OOC)
OCC Start-Ups Enter the Fray
Select Organ-On-A-Chip Start-Ups & Their Specialties
Biochip Implants Set to Make Big Gains
Biochips Aid in Alleviating Issues Associated with
Immunological Studies
Challenges for Widespread Adoption
Drug Discovery Applications to Drive Market
Growing Preference for DNA/Protein Biochips in Personalized
Medicine
Global Personalized Medicine Market: Revenues in US$ Million
for the Years 2019, 2021, 2023 and 2025
Microphysiological Systems to Take Personalized Medicine Much
Farther
Biochip Array Technology Enables Reliable and Accurate
Investigation of Metabolic Syndrome
Proteomics and Genomics Drive Opportunities for Biochips
Increasing Application of Genomics and Proteomics in Cancer
Diagnostics and Treatment to Drive Growth
Breakdown of Total Number of Cancer Cases by Region: 2020
Breakdown of Total Number of Cancer Cases by Type: 2020
Global Cancer Incidence: Number of New Cancer Cases in Million
for the Years 2018, 2020, 2025, 2030, 2035 and 2040
Potential Application of Biochips in Diabetes Diagnosis and
Management Unfurl New Growth Opportunities
World Diabetes and Population Statistics (2019, 2030 & 2045)
World Diabetes Prevalence (2000-2019)
Rise in Infectious Diseases and Need for High-Troughput
Diagnosis Drive Interest in Biochips
Infection Rates of Viruses ((per infected person)) Involved in
Outbreaks Worldwide: 2020
Infectious Diseases Related Mortality High Among Children Below
5 Years: Breakdown of Leading Causes of Death in Children
Below 5 Years (in %)
Global Number of Deaths Caused Due to Communicable Diseases (In
000s)
Agriculture Sector: Niche Vertical
Development of Protein Microarrays for the Field of
Diagnostics: Key Challenges
Biochip Industry Thrives on Innovation
Researchers at UCI Develop Machine Learning-Assisted Biochip
New Biochip Combines Nanoparticle Printing and AI for Tumor
Analysis
Axbio Introduces Smartbiochip
Multi-Dimensional Printing Technology Enables Development of
New Biochip Printing Technique
MIT Develops Neuromorphic Chip Capable of Mimicking Human Brain
Biochips from AYOXXA: A Giant Leap in Protein Multiplexing
Biochip Innovations in Drug Discovery Applications
Industry Challenges
Standardization: A Key Challenge
High Costs Restrain Growth
Precise Protein Detection: A Challenge

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Recent Past, Current & Future Analysis for DNA
Chip by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America and Rest of World Markets -
Independent Analysis of Annual Revenues in US$ Million for
Years 2022 through 2030 and % CAGR

Table 2: World Historic Review for DNA Chip by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America and Rest of World Markets - Independent Analysis of
Annual Revenues in US$ Million for Years 2014 through 2021 and
% CAGR

Table 3: World 16-Year Perspective for DNA Chip by Geographic
Region - Percentage Breakdown of Value Revenues for USA,
Canada, Japan, China, Europe, Asia-Pacific, Latin America and
Rest of World for Years 2014, 2023 & 2030

Table 4: World Recent Past, Current & Future Analysis for
Lab-on-a-Chip by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America and Rest of World Markets -
Independent Analysis of Annual Revenues in US$ Million for
Years 2022 through 2030 and % CAGR

Table 5: World Historic Review for Lab-on-a-Chip by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America and Rest of World Markets - Independent Analysis of
Annual Revenues in US$ Million for Years 2014 through 2021 and
% CAGR

Table 6: World 16-Year Perspective for Lab-on-a-Chip by
Geographic Region - Percentage Breakdown of Value Revenues for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America
and Rest of World for Years 2014, 2023 & 2030

Table 7: World Recent Past, Current & Future Analysis for
Protein Chip by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America and Rest of World Markets -
Independent Analysis of Annual Revenues in US$ Million for
Years 2022 through 2030 and % CAGR

Table 8: World Historic Review for Protein Chip by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America and Rest of World Markets - Independent Analysis of
Annual Revenues in US$ Million for Years 2014 through 2021 and
% CAGR

Table 9: World 16-Year Perspective for Protein Chip by
Geographic Region - Percentage Breakdown of Value Revenues for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America
and Rest of World for Years 2014, 2023 & 2030

Table 10: World Recent Past, Current & Future Analysis for
Other Product Types by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America and Rest of World
Markets - Independent Analysis of Annual Revenues in US$
Million for Years 2022 through 2030 and % CAGR

Table 11: World Historic Review for Other Product Types by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America and Rest of World Markets -
Independent Analysis of Annual Revenues in US$ Million for
Years 2014 through 2021 and % CAGR

Table 12: World 16-Year Perspective for Other Product Types by
Geographic Region - Percentage Breakdown of Value Revenues for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America
and Rest of World for Years 2014, 2023 & 2030

Table 13: World Recent Past, Current & Future Analysis for Drug
Discovery & Development by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America and Rest of
World Markets - Independent Analysis of Annual Revenues in US$
Million for Years 2022 through 2030 and % CAGR

Table 14: World Historic Review for Drug Discovery &
Development by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America and Rest of World Markets -
Independent Analysis of Annual Revenues in US$ Million for
Years 2014 through 2021 and % CAGR

Table 15: World 16-Year Perspective for Drug Discovery &
Development by Geographic Region - Percentage Breakdown of
Value Revenues for USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America and Rest of World for Years 2014,
2023 & 2030

Table 16: World Recent Past, Current & Future Analysis for
Disease Diagnostics by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America and Rest of World
Markets - Independent Analysis of Annual Revenues in US$
Million for Years 2022 through 2030 and % CAGR

Table 17: World Historic Review for Disease Diagnostics by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America and Rest of World Markets -
Independent Analysis of Annual Revenues in US$ Million for
Years 2014 through 2021 and % CAGR

Table 18: World 16-Year Perspective for Disease Diagnostics by
Geographic Region - Percentage Breakdown of Value Revenues for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America
and Rest of World for Years 2014, 2023 & 2030

Table 19: World Recent Past, Current & Future Analysis for
Genomics by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America and Rest of World Markets -
Independent Analysis of Annual Revenues in US$ Million for
Years 2022 through 2030 and % CAGR

Table 20: World Historic Review for Genomics by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America and Rest of World Markets - Independent Analysis of
Annual Revenues in US$ Million for Years 2014 through 2021 and
% CAGR

Table 21: World 16-Year Perspective for Genomics by Geographic
Region - Percentage Breakdown of Value Revenues for USA,
Canada, Japan, China, Europe, Asia-Pacific, Latin America and
Rest of World for Years 2014, 2023 & 2030

Table 22: World Recent Past, Current & Future Analysis for
Proteomics by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America and Rest of World Markets -
Independent Analysis of Annual Revenues in US$ Million for
Years 2022 through 2030 and % CAGR

Table 23: World Historic Review for Proteomics by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America and Rest of World Markets - Independent Analysis of
Annual Revenues in US$ Million for Years 2014 through 2021 and
% CAGR

Table 24: World 16-Year Perspective for Proteomics by
Geographic Region - Percentage Breakdown of Value Revenues for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America
and Rest of World for Years 2014, 2023 & 2030

Table 25: World Recent Past, Current & Future Analysis for
Agriculture by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America and Rest of World Markets -
Independent Analysis of Annual Revenues in US$ Million for
Years 2022 through 2030 and % CAGR

Table 26: World Historic Review for Agriculture by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America and Rest of World Markets - Independent Analysis of
Annual Revenues in US$ Million for Years 2014 through 2021 and
% CAGR

Table 27: World 16-Year Perspective for Agriculture by
Geographic Region - Percentage Breakdown of Value Revenues for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America
and Rest of World for Years 2014, 2023 & 2030

Table 28: World Recent Past, Current & Future Analysis for
Other Applications by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America and Rest of World
Markets - Independent Analysis of Annual Revenues in US$
Million for Years 2022 through 2030 and % CAGR

Table 29: World Historic Review for Other Applications by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America and Rest of World Markets -
Independent Analysis of Annual Revenues in US$ Million for
Years 2014 through 2021 and % CAGR

Table 30: World 16-Year Perspective for Other Applications by
Geographic Region - Percentage Breakdown of Value Revenues for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America
and Rest of World for Years 2014, 2023 & 2030

Table 31: World Biochips Market Analysis of Annual Sales in US$
Million for Years 2014 through 2030

Table 32: World Recent Past, Current & Future Analysis for
Biochips by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America and Rest of World Markets -
Independent Analysis of Annual Revenues in US$ Million for
Years 2022 through 2030 and % CAGR

Table 33: World Historic Review for Biochips by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America and Rest of World Markets - Independent Analysis of
Annual Revenues in US$ Million for Years 2014 through 2021 and
% CAGR

Table 34: World 16-Year Perspective for Biochips by Geographic
Region - Percentage Breakdown of Value Revenues for USA,
Canada, Japan, China, Europe, Asia-Pacific, Latin America and
Rest of World Markets for Years 2014, 2023 & 2030

III. MARKET ANALYSIS

UNITED STATES
Biochips Market Presence - Strong/Active/Niche/Trivial - Key
Competitors in the United States for 2023 (E)
Table 35: USA Recent Past, Current & Future Analysis for
Biochips by Product Type - DNA Chip, Lab-on-a-Chip, Protein
Chip and Other Product Types - Independent Analysis of Annual
Revenues in US$ Million for the Years 2022 through 2030 and %
CAGR

Table 36: USA Historic Review for Biochips by Product Type -
DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types
Markets - Independent Analysis of Annual Revenues in US$
Million for Years 2014 through 2021 and % CAGR

Table 37: USA 16-Year Perspective for Biochips by Product Type -
Percentage Breakdown of Value Revenues for DNA Chip,
Lab-on-a-Chip, Protein Chip and Other Product Types for the
Years 2014, 2023 & 2030

Table 38: USA Recent Past, Current & Future Analysis for
Biochips by Application - Drug Discovery & Development, Disease
Diagnostics, Genomics, Proteomics, Agriculture and Other
Applications - Independent Analysis of Annual Revenues in US$
Million for the Years 2022 through 2030 and % CAGR

Table 39: USA Historic Review for Biochips by Application -
Drug Discovery & Development, Disease Diagnostics, Genomics,
Proteomics, Agriculture and Other Applications Markets -
Independent Analysis of Annual Revenues in US$ Million for
Years 2014 through 2021 and % CAGR

Table 40: USA 16-Year Perspective for Biochips by Application -
Percentage Breakdown of Value Revenues for Drug Discovery &
Development, Disease Diagnostics, Genomics, Proteomics,
Agriculture and Other Applications for the Years 2014, 2023 &
2030

CANADA
Table 41: Canada Recent Past, Current & Future Analysis for
Biochips by Product Type - DNA Chip, Lab-on-a-Chip, Protein
Chip and Other Product Types - Independent Analysis of Annual
Revenues in US$ Million for the Years 2022 through 2030 and %
CAGR

Table 42: Canada Historic Review for Biochips by Product Type -
DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types
Markets - Independent Analysis of Annual Revenues in US$
Million for Years 2014 through 2021 and % CAGR

Table 43: Canada 16-Year Perspective for Biochips by Product
Type - Percentage Breakdown of Value Revenues for DNA Chip,
Lab-on-a-Chip, Protein Chip and Other Product Types for the
Years 2014, 2023 & 2030

Table 44: Canada Recent Past, Current & Future Analysis for
Biochips by Application - Drug Discovery & Development, Disease
Diagnostics, Genomics, Proteomics, Agriculture and Other
Applications - Independent Analysis of Annual Revenues in US$
Million for the Years 2022 through 2030 and % CAGR

Table 45: Canada Historic Review for Biochips by Application -
Drug Discovery & Development, Disease Diagnostics, Genomics,
Proteomics, Agriculture and Other Applications Markets -
Independent Analysis of Annual Revenues in US$ Million for
Years 2014 through 2021 and % CAGR

Table 46: Canada 16-Year Perspective for Biochips by
Application - Percentage Breakdown of Value Revenues for Drug
Discovery & Development, Disease Diagnostics, Genomics,
Proteomics, Agriculture and Other Applications for the Years
2014, 2023 & 2030

JAPAN
Biochips Market Presence - Strong/Active/Niche/Trivial - Key
Competitors in Japan for 2023 (E)
Table 47: Japan Recent Past, Current & Future Analysis for
Biochips by Product Type - DNA Chip, Lab-on-a-Chip, Protein
Chip and Other Product Types - Independent Analysis of Annual
Revenues in US$ Million for the Years 2022 through 2030 and %
CAGR

Table 48: Japan Historic Review for Biochips by Product Type -
DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types
Markets - Independent Analysis of Annual Revenues in US$
Million for Years 2014 through 2021 and % CAGR

Table 49: Japan 16-Year Perspective for Biochips by Product
Type - Percentage Breakdown of Value Revenues for DNA Chip,
Lab-on-a-Chip, Protein Chip and Other Product Types for the
Years 2014, 2023 & 2030

Table 50: Japan Recent Past, Current & Future Analysis for
Biochips by Application - Drug Discovery & Development, Disease
Diagnostics, Genomics, Proteomics, Agriculture and Other
Applications - Independent Analysis of Annual Revenues in US$
Million for the Years 2022 through 2030 and % CAGR

Table 51: Japan Historic Review for Biochips by Application -
Drug Discovery & Development, Disease Diagnostics, Genomics,
Proteomics, Agriculture and Other Applications Markets -
Independent Analysis of Annual Revenues in US$ Million for
Years 2014 through 2021 and % CAGR

Table 52: Japan 16-Year Perspective for Biochips by Application -
Percentage Breakdown of Value Revenues for Drug Discovery &
Development, Disease Diagnostics, Genomics, Proteomics,
Agriculture and Other Applications for the Years 2014, 2023 &
2030

CHINA
Biochips Market Presence - Strong/Active/Niche/Trivial - Key
Competitors in China for 2023 (E)
Table 53: China Recent Past, Current & Future Analysis for
Biochips by Product Type - DNA Chip, Lab-on-a-Chip, Protein
Chip and Other Product Types - Independent Analysis of Annual
Revenues in US$ Million for the Years 2022 through 2030 and %
CAGR

Table 54: China Historic Review for Biochips by Product Type -
DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types
Markets - Independent Analysis of Annual Revenues in US$
Million for Years 2014 through 2021 and % CAGR

Table 55: China 16-Year Perspective for Biochips by Product
Type - Percentage Breakdown of Value Revenues for DNA Chip,
Lab-on-a-Chip, Protein Chip and Other Product Types for the
Years 2014, 2023 & 2030

Table 56: China Recent Past, Current & Future Analysis for
Biochips by Application - Drug Discovery & Development, Disease
Diagnostics, Genomics, Proteomics, Agriculture and Other
Applications - Independent Analysis of Annual Revenues in US$
Million for the Years 2022 through 2030 and % CAGR

Table 57: China Historic Review for Biochips by Application -
Drug Discovery & Development, Disease Diagnostics, Genomics,
Proteomics, Agriculture and Other Applications Markets -
Independent Analysis of Annual Revenues in US$ Million for
Years 2014 through 2021 and % CAGR

Table 58: China 16-Year Perspective for Biochips by Application -
Percentage Breakdown of Value Revenues for Drug Discovery &
Development, Disease Diagnostics, Genomics, Proteomics,
Agriculture and Other Applications for the Years 2014, 2023 &
2030

EUROPE
Biochips Market Presence - Strong/Active/Niche/Trivial - Key
Competitors in Europe for 2023 (E)
Table 59: Europe Recent Past, Current & Future Analysis for
Biochips by Product Type - DNA Chip, Lab-on-a-Chip, Protein
Chip and Other Product Types - Independent Analysis of Annual
Revenues in US$ Million for the Years 2022 through 2030 and %
CAGR

Table 60: Europe Historic Review for Biochips by Product Type -
DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types
Markets - Independent Analysis of Annual Revenues in US$
Million for Years 2014 through 2021 and % CAGR

Table 61: Europe 16-Year Perspective for Biochips by Product
Type - Percentage Breakdown of Value Revenues for DNA Chip,
Lab-on-a-Chip, Protein Chip and Other Product Types for the
Years 2014, 2023 & 2030

Table 62: Europe Recent Past, Current & Future Analysis for
Biochips by Application - Drug Discovery & Development, Disease
Diagnostics, Genomics, Proteomics, Agriculture and Other
Applications - Independent Analysis of Annual Revenues in US$
Million for the Years 2022 through 2030 and % CAGR

Table 63: Europe Historic Review for Biochips by Application -
Drug Discovery & Development, Disease Diagnostics, Genomics,
Proteomics, Agriculture and Other Applications Markets -
Independent Analysis of Annual Revenues in US$ Million for
Years 2014 through 2021 and % CAGR

Table 64: Europe 16-Year Perspective for Biochips by
Application - Percentage Breakdown of Value Revenues for Drug
Discovery & Development, Disease Diagnostics, Genomics,
Proteomics, Agriculture and Other Applications for the Years
2014, 2023 & 2030

Table 65: Europe Recent Past, Current & Future Analysis for
Biochips by Geographic Region - France, Germany, Italy, UK,
Spain, Russia and Rest of Europe Markets - Independent Analysis
of Annual Revenues in US$ Million for Years 2022 through 2030
and % CAGR

Table 66: Europe Historic Review for Biochips by Geographic
Region - France, Germany, Italy, UK, Spain, Russia and Rest of
Europe Markets - Independent Analysis of Annual Revenues in US$
Million for Years 2014 through 2021 and % CAGR

Table 67: Europe 16-Year Perspective for Biochips by Geographic
Region - Percentage Breakdown of Value Revenues for France,
Germany, Italy, UK, Spain, Russia and Rest of Europe Markets
for Years 2014, 2023 & 2030

FRANCE
Biochips Market Presence - Strong/Active/Niche/Trivial - Key
Competitors in France for 2023 (E)
Table 68: France Recent Past, Current & Future Analysis for
Biochips by Product Type - DNA Chip, Lab-on-a-Chip, Protein
Chip and Other Product Types - Independent Analysis of Annual
Revenues in US$ Million for the Years 2022 through 2030 and %
CAGR

Table 69: France Historic Review for Biochips by Product Type -
DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types
Markets - Independent Analysis of Annual Revenues in US$
Million for Years 2014 through 2021 and % CAGR

Table 70: France 16-Year Perspective for Biochips by Product
Type - Percentage Breakdown of Value Revenues for DNA Chip,
Lab-on-a-Chip, Protein Chip and Other Product Types for the
Years 2014, 2023 & 2030

Table 71: France Recent Past, Current & Future Analysis for
Biochips by Application - Drug Discovery & Development, Disease
Diagnostics, Genomics, Proteomics, Agriculture and Other
Applications - Independent Analysis of Annual Revenues in US$
Million for the Years 2022 through 2030 and % CAGR

Table 72: France Historic Review for Biochips by Application -
Drug Discovery & Development, Disease Diagnostics, Genomics,
Proteomics, Agriculture and Other Applications Markets -
Independent Analysis of Annual Revenues in US$ Million for
Years 2014 through 2021 and % CAGR

Table 73: France 16-Year Perspective for Biochips by
Application - Percentage Breakdown of Value Revenues for Drug
Discovery & Development, Disease Diagnostics, Genomics,
Proteomics, Agriculture and Other Applications for the Years
2014, 2023 & 2030

GERMANY
Biochips Market Presence - Strong/Active/Niche/Trivial - Key
Competitors in Germany for 2023 (E)
Table 74: Germany Recent Past, Current & Future Analysis for
Biochips by Product Type - DNA Chip, Lab-on-a-Chip, Protein
Chip and Other Product Types - Independent Analysis of Annual
Revenues in US$ Million for the Years 2022 through 2030 and %
CAGR

Table 75: Germany Historic Review for Biochips by Product Type -
DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types
Markets - Independent Analysis of Annual Revenues in US$
Million for Years 2014 through 2021 and % CAGR

Table 76: Germany 16-Year Perspective for Biochips by Product
Type - Percentage Breakdown of Value Revenues for DNA Chip,
Lab-on-a-Chip, Protein Chip and Other Product Types for the
Years 2014, 2023 & 2030

Table 77: Germany Recent Past, Current & Future Analysis for
Biochips by Application - Drug Discovery & Development, Disease
Diagnostics, Genomics, Proteomics, Agriculture and Other
Applications - Independent Analysis of Annual Revenues in US$
Million for the Years 2022 through 2030 and % CAGR

Table 78: Germany Historic Review for Biochips by Application -
Drug Discovery & Development, Disease Diagnostics, Genomics,
Proteomics, Agriculture and Other Applications Markets -
Independent Analysis of Annual Revenues in US$ Million for
Years 2014 through 2021 and % CAGR

Table 79: Germany 16-Year Perspective for Biochips by
Application - Percentage Breakdown of Value Revenues for Drug
Discovery & Development, Disease Diagnostics, Genomics,
Proteomics, Agriculture and Other Applications for the Years
2014, 2023 & 2030

ITALY
Table 80: Italy Recent Past, Current & Future Analysis for
Biochips by Product Type - DNA Chip, Lab-on-a-Chip, Protein
Chip and Other Product Types - Independent Analysis of Annual
Revenues in US$ Million for the Years 2022 through 2030 and %
CAGR

Table 81: Italy Historic Review for Biochips by Product Type -
DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types
Markets - Independent Analysis of Annual Revenues in US$
Million for Years 2014 through 2021 and % CAGR

Table 82: Italy 16-Year Perspective for Biochips by Product
Type - Percentage Breakdown of Value Revenues for DNA Chip,
Lab-on-a-Chip, Protein Chip and Other Product Types for the
Years 2014, 2023 & 2030

Table 83: Italy Recent Past, Current & Future Analysis for
Biochips by Application - Drug Discovery & Development, Disease
Diagnostics, Genomics, Proteomics, Agriculture and Other
Applications - Independent Analysis of Annual Revenues in US$
Million for the Years 2022 through 2030 and % CAGR

Table 84: Italy Historic Review for Biochips by Application -
Drug Discovery & Development, Disease Diagnostics, Genomics,
Proteomics, Agriculture and Other Applications Markets -
Independent Analysis of Annual Revenues in US$ Million for
Years 2014 through 2021 and % CAGR

Table 85: Italy 16-Year Perspective for Biochips by Application -
Percentage Breakdown of Value Revenues for Drug Discovery &
Development, Disease Diagnostics, Genomics, Proteomics,
Agriculture and Other Applications for the Years 2014, 2023 &
2030

UNITED KINGDOM
Biochips Market Presence - Strong/Active/Niche/Trivial - Key
Competitors in the United Kingdom for 2023 (E)
Table 86: UK Recent Past, Current & Future Analysis for
Biochips by Product Type - DNA Chip, Lab-on-a-Chip, Protein
Chip and Other Product Types - Independent Analysis of Annual
Revenues in US$ Million for the Years 2022 through 2030 and %
CAGR

Table 87: UK Historic Review for Biochips by Product Type - DNA
Chip, Lab-on-a-Chip, Protein Chip and Other Product Types
Markets - Independent Analysis of Annual Revenues in US$
Million for Years 2014 through 2021 and % CAGR

Table 88: UK 16-Year Perspective for Biochips by Product Type -
Percentage Breakdown of Value Revenues for DNA Chip,
Lab-on-a-Chip, Protein Chip and Other Product Types for the
Years 2014, 2023 & 2030

Table 89: UK Recent Past, Current & Future Analysis for
Biochips by Application - Drug Discovery & Development, Disease
Diagnostics, Genomics, Proteomics, Agriculture and Other
Applications - Independent Analysis of Annual Revenues in US$
Million for the Years 2022 through 2030 and % CAGR

Table 90: UK Historic Review for Biochips by Application - Drug
Discovery & Development, Disease Diagnostics, Genomics,
Proteomics, Agriculture and Other Applications Markets -
Independent Analysis of Annual Revenues in US$ Million for
Years 2014 through 2021 and % CAGR

Table 91: UK 16-Year Perspective for Biochips by Application -
Percentage Breakdown of Value Revenues for Drug Discovery &
Development, Disease Diagnostics, Genomics, Proteomics,
Agriculture and Other Applications for the Years 2014, 2023 &
2030

SPAIN
Table 92: Spain Recent Past, Current & Future Analysis for
Biochips by Product Type - DNA Chip, Lab-on-a-Chip, Protein
Chip and Other Product Types - Independent Analysis of Annual
Revenues in US$ Million for the Years 2022 through 2030 and %
CAGR

Table 93: Spain Historic Review for Biochips by Product Type -
DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types
Markets - Independent Analysis of Annual Revenues in US$
Million for Years 2014 through 2021 and % CAGR

Table 94: Spain 16-Year Perspective for Biochips by Product
Type - Percentage Breakdown of Value Revenues for DNA Chip,
Lab-on-a-Chip, Protein Chip and Other Product Types for the
Years 2014, 2023 & 2030

Table 95: Spain Recent Past, Current & Future Analysis for
Biochips by Application - Drug Discovery & Development, Disease
Diagnostics, Genomics, Proteomics, Agriculture and Other
Applications - Independent Analysis of Annual Revenues in US$
Million for the Years 2022 through 2030 and % CAGR

Table 96: Spain Historic Review for Biochips by Application -
Drug Discovery & Development, Disease Diagnostics, Genomics,
Proteomics, Agriculture and Other Applications Markets -
Independent Analysis of Annual Revenues in US$ Million for
Years 2014 through 2021 and % CAGR

Table 97: Spain 16-Year Perspective for Biochips by Application -
Percentage Breakdown of Value Revenues for Drug Discovery &
Development, Disease Diagnostics, Genomics, Proteomics,
Agriculture and Other Applications for the Years 2014, 2023 &
2030

RUSSIA
Table 98: Russia Recent Past, Current & Future Analysis for
Biochips by Product Type - DNA Chip, Lab-on-a-Chip, Protein
Chip and Other Product Types - Independent Analysis of Annual
Revenues in US$ Million for the Years 2022 through 2030 and %
CAGR

Table 99: Russia Historic Review for Biochips by Product Type -
DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types
Markets - Independent Analysis of Annual Revenues in US$
Million for Years 2014 through 2021 and % CAGR

Table 100: Russia 16-Year Perspective for Biochips by Product
Type - Percentage Breakdown of Value Revenues for DNA Chip,
Lab-on-a-Chip, Protein Chip and Other Product Types for the
Years 2014, 2023 & 2030

Table 101: Russia Recent Past, Current & Future Analysis for
Biochips by Application - Drug Discovery & Development, Disease
Diagnostics, Genomics, Proteomics, Agriculture and Other
Applications - Independent Analysis of Annual Revenues in US$
Million for the Years 2022 through 2030 and % CAGR

Table 102: Russia Historic Review for Biochips by Application -
Drug Discovery & Development, Disease Diagnostics, Genomics,
Proteomics, Agriculture and Other Applications Markets -
Independent Analysis of Annual Revenues in US$ Million for
Years 2014 through 2021 and % CAGR

Table 103: Russia 16-Year Perspective for Biochips by
Application - Percentage Breakdown of Value Revenues for Drug
Discovery & Development, Disease Diagnostics, Genomics,
Proteomics, Agriculture and Other Applications for the Years
2014, 2023 & 2030

REST OF EUROPE
Table 104: Rest of Europe Recent Past, Current & Future
Analysis for Biochips by Product Type - DNA Chip,
Lab-on-a-Chip, Protein Chip and Other Product Types -
Independent Analysis of Annual Revenues in US$ Million for the
Years 2022 through 2030 and % CAGR

Table 105: Rest of Europe Historic Review for Biochips by
Product Type - DNA Chip, Lab-on-a-Chip, Protein Chip and Other
Product Types Markets - Independent Analysis of Annual Revenues
in US$ Million for Years 2014 through 2021 and % CAGR

Table 106: Rest of Europe 16-Year Perspective for Biochips by
Product Type - Percentage Breakdown of Value Revenues for DNA
Chip, Lab-on-a-Chip, Protein Chip and Other Product Types for
the Years 2014, 2023 & 2030

Table 107: Rest of Europe Recent Past, Current & Future
Analysis for Biochips by Application - Drug Discovery &
Development, Disease Diagnostics, Genomics, Proteomics,
Agriculture and Other Applications - Independent Analysis of
Annual Revenues in US$ Million for the Years 2022 through 2030
and % CAGR

Table 108: Rest of Europe Historic Review for Biochips by
Application - Drug Discovery & Development, Disease
Diagnostics, Genomics, Proteomics, Agriculture and Other
Applications Markets - Independent Analysis of Annual Revenues
in US$ Million for Years 2014 through 2021 and % CAGR

Table 109: Rest of Europe 16-Year Perspective for Biochips by

Please contact our Customer Support Center to get the complete Table of Contents

Methodology

Our market research methodology is designed to provide the clients with comprehensive and accurate information on various industries and markets. It includes data collection, primary interviews, macro-economic factor analysis, country-level data analysis etc.

The data is gathered from a wide range of sources, including industry reports, government statistics, and company financials. This data is then analyzed and cross-referenced to ensure its accuracy and reliability. Next, primary interviews are conducted with industry experts and key stakeholders to gather their insights and perspectives on the market. This information is then combined with the data collected to provide a complete picture of the market. Macro-economic factor analysis is also carried out to understand the impact of external factors on the market. Finally, country-level data analysis is performed to understand the market dynamics in specific regions and countries.

Reportlinker's market research methodology is designed to provide clients with a clear understanding of the market, its trends, and its future potential.